ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to ...

The notion of glycaemic index is not new, and the adoption of drugs to slow the absorption of carbohydrates, most especially using glycoside inhibitors, is currently recognised in diabetes management.

These biofilms act as thick barriers limiting the entry of drugs and helping the bacteria ... In people with diabetes, it infects wounds, which end up healing slowly, leading to complications ...

including that it may reduce the effectiveness of certain medications and is thought to have estrogen-like properties (problematic for those with hormone-related conditions). People with heart ...

Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Pharmaceutical firm, Eva Pharma, has introduced its range of diabetes medications to the Nigerian market, pledging to offer premium healthcare solutions at affordable prices. Eva Pharma announced ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new ...

Some of these medications started as treatments for type 2 diabetes but quickly gained favor for their ability to help people lose weight. They often work by affecting hormones in the brain and ...